Grand Rounds: Improving quality of patient-centred care
Omission of radiotherapy is a reasonable option for women age 65 or older who receive hormone therapy after breast-conserving surgery for hormone receptor-positive, axillary node-negative breast cancer, according to results of the PRIME 2 trial presented at the 2013 San Antonio Breast Cancer Symposium.
Grand Rounds: Improving quality of patient-centred care
The advantages of IORT for early breast cancer treatment
The pros and cons of breast IORT and ultra hypofractionation (FR)
Single-dose IORT during lumpectomy for breast cancer an innovative patient-centred treatment
Global adoption of single-shot targeted IORT for breast cancer
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
IORT at Institute Paoli-Calmettes in France
IORT at the WITS University in South Africa
IORT at hospital Del Mar Barcelona in Spain